Investigating the effectiveness of oral tablet based on the Cuscuta epithymum on endometrioma

Phase 2

Recruiting

• Conditions: Endometrioma.; Malignant neoplasm of endometrium; C54.1

• Registration Number: IRCT20220108053669N4
• Lead Sponsor: Mazandaran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 January 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 68

Inclusion Criteria

Endometriosis with pelvic pain and ovarian cyst over 2 cm
Absence of Müllerian fibrosis adenomyosis and myoma
Not taking medication such as painkillers
Consent

Exclusion Criteria

Patient dissatisfaction
Occurrence of pregnancy
Drug complication

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The effect of drugs on patients pain. Timepoint: Monthly since intervention, two months. Method of measurement: VAS(Visual Analogue Scale).

Secondary Outcome Measures

Name	Time	Method
Drug effect on ovarian cyst size of patient. Timepoint: Two month since the beginning of intervention. Method of measurement: sonography.;Drug effect on the quality of life of patients. Timepoint: Monthly since intervention, two month. Method of measurement: EHP-30 Questionnaire.;Drug effect on the amount of painkillers usage in patients. Timepoint: Monthly since intervention, two month. Method of measurement: asking from patients.